GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Phibro Animal Health Corp (FRA:PB8) » Definitions » Cash Flow for Lease Financing

Phibro Animal Health (FRA:PB8) Cash Flow for Lease Financing : €0.0 Mil (TTM As of Sep. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Phibro Animal Health Cash Flow for Lease Financing?

Phibro Animal Health's Cash Flow for Lease Financing for the three months ended in Sep. 2024 was €0.0 Mil. Phibro Animal Health's Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Sep. 2024 was €0.0 Mil.

Compared with last quarter (€0.0 Mil in Jun. 2024 ), Phibro Animal Health's Cash Flow for Lease Financing remained the same in Sep. 2024 (€0.0 Mil).

Phibro Animal Health Cash Flow for Lease Financing Historical Data

The historical data trend for Phibro Animal Health's Cash Flow for Lease Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Phibro Animal Health Cash Flow for Lease Financing Chart

Phibro Animal Health Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Cash Flow for Lease Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Phibro Animal Health Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cash Flow for Lease Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Phibro Animal Health Cash Flow for Lease Financing Calculation

Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing.


Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Phibro Animal Health Cash Flow for Lease Financing Related Terms

Thank you for viewing the detailed overview of Phibro Animal Health's Cash Flow for Lease Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Phibro Animal Health Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Phibro Animal Health Corp (FRA:PB8) » Definitions » Cash Flow for Lease Financing
Comparable Companies
EOLS HROW SIGA PETQ PROC BKUH ORGO AMRX LFCR RGC ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
PAHC:USA
Address
300 Frank W. Burr Boulevard, Suite 21, 3rd Floor, Glenpointe Centre East, Teaneck, NJ, USA, 07666-6712
Website
https://www.pahc.com
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.

Phibro Animal Health Headlines

No Headlines